Intellectual property related to the Australian Life Sciences sector

Compiled by Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909 (29 September 2017)

The World Intellectual Property Organisation publishes new PCT patent applications every Thursday. Australian applicants generally have 12 or 13 healthcare and biotech-related patent applications published each month while New Zealand applicants have two or three a month.

Australian applications

Here are the 135 PCT patent applications relevant to Australia's Life Sciences sector that published in 2015, for a publication rate of 2.6 applications per week:

WO/2015/196258, Enzyme interacting agents, Monash University, University of South Australia and SA Pathology, 30 December 2015
WO/2015/196250, Lipid comprising docosapentaenoic acid, Commonwealth Scientific and Industrial Research Organisation, Grains Research and Development Corporation and Nuseed Pty Ltd, 30 December 2015
WO/2015/196245, Modulation of osteogenesis and or angiogenesis by modulating peroxidase functionality, University of Adelaide, 30 December 2015
WO/2015/191799, Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof, Bionomics Ltd and Merck & Co., 17 December 2015
WO/2015/191595, A novel formulation of meloxicam, iCeutica Pty Ltd, 17 December 2015
WO/2015/188235, Dietary supplement, Gratuk Technologies Pty Ltd, 17 December 2015
WO/2015/188223, Device and method to treat or prevent joint degeneration, OBJ Ltd, 17 December 2015
WO/2015/184510, Dendrimer-drug conjugates, Starpharma Ltd, 10 December 2015
WO/2015/184509, Methods of treating neurodevelopmental diseases and disorders, Deakin University and Florey Institute of Neuroscience and Mental Health, 10 December 2015
WO/2015/184494, Process for preparation of caffeine extract, Abroad Promotions Pty Ltd, 10 December 2015
WO/2015/181641, Combination of lenalidomide or pomalidomide and CD38 antibody-attenuated interferon-alpha constructs, and the use thereof, Teva Pharmaceutical Industries, 3 December 2015
WO/2015/179918, Modulation of cellular stress, University of Queensland, 3 December 2015
WO/2015/179893, A therapeutic protocol for treating ovarian cancer, Bionomics Ltd, 3 December 2015
WO/2015/176135, Omega-3 analogues, University of Sydney and University of Technology Sydney, 26 November 2015
WO/2015/176104, Bak binding proteins, Walter and Eliza Hall Institute of Medical Research, 26 November 2015
WO/2015/172203, Methods for inhibiting necroptosis, Catalyst Therapeutics Pty Ltd, 19 November 2015
WO/2015/172196, Heterocyclic compounds and use of same, Monash University and University of Western Australia, 19 November 2015
WO/2015/172191, Probiotic compositions and uses thereof for treatment of obesity-related disorders, Medlab Clinical Ltd, 19 November 2015
WO/2015/168741, Extended shelf life wound healing formulation, Mark Deacon-Shaw and Graham Kelly, 12 November 2015
WO/2015/168726, Method for treating renal cell carcinoma, Sirtex Medical Ltd, 12 November 2015
WO/2015/161348, Agents and methods of treatment, Hexima Ltd, 29 October 2015
WO/2015/161346, Agents and methods for treatment of pathogens, Hexima Ltd, 29 October 2015
WO/2015/159103, Piperazine derivatives for treating disorders, University of Nottingham and University of New South Wales, 22 October 2015
WO/2015/157829, Modified relaxin B chain peptides, Florey Institute of Neuroscience and Mental Health, 22 October 2015
WO/2015/157820, Group A streptococcus vaccine, Griffith University, 22 October 2015
WO/2015/157794, Compositions and methods for the treatment or prevention of neurodegenerative disorders, Northern Sydney Local Health District, 22 October 2015
WO/2015/154141, Methods and compositions for delivering an extract of Piper Methysticum, Ambrosios Kambouris, 15 October 2015
WO/2015/154140, Methods and compositions for delivering a probiotic, Ambrosios Kambouris, 15 October 2015
WO/2015/154139, Half-life extended Factor FVIIIa protein for prevention and treatment of bleeding and dosing regimens therefor, CSL Ltd, 15 October 2015
WO/2015/154126, Liposomal compound and compositions containing the compound, Jurlique International Pty Ltd, 15 October 2015
WO/2015/149135, Process of manufacturing a stable dispersion for a dietary supplement, Sanofi-Aventis Healthcare Pty Ltd, 8 October 2015
WO/2015/149131, Polymyxin derivatives as antimicrobial compounds, Monash University, 8 October 2015
WO/2015/149130, Immunological reagents and uses therefor, University of Queensland, Monash University and University if Melbourne, 8 October 2015
WO/2015/149129, A prognostic assay for success of assisted reproductive technology, Hudson Institute of Medical Research, 8 October 2015
WO/2015/149105, Method for treating Chronic Lymphocytic Leukemia, Bionomics Ltd, 8 October 2015
WO/2015/143507, A dentifrice composition, Biodental Remin Ltd, 1 October 2015
WO/2015/143483, Method for improving feed efficiency in ruminants, Rivalea (Australia) Pty Ltd, 1 October 2015
WO/2015/139093, Stable gene transfer to proliferating cells, Sydney Children's Hospitals Network, Children's Medical Research Institute and Mount Sinai Hospital (Canada), 24 September 2015
WO/2015/139085, Antimicrobial sanitizer compositions and their use, GFS Corporation Aus Pty Ltd, 24 September 2015
WO/2015/139079, Anti-biofilm polymer, University of New South Wales, 24 September 2015
WO/2015/139074, Antimicrobial air sanitizer compositions and their use, Air Sanz Holdings Pty Ltd, 24 September 2015
WO/2015/135024, Adjuvant therapy to standard of care (SOC) diuretic treatment, Madeleine Pharmaceuticals Pty Ltd, 17 September 2015
WO/2015/135021, Nail polish remover, Rochelle Mercado and Fiona Reeve, 17 September 2015
WO/2015/135016, Compositions that assist skin healing and/or maintain skin health, Ego Pharmaceuticals Pty Ltd, 17 September 2015
WO/2015/131245, Sepsis treatment, La Trobe University, 11 September 2015
WO/2015/131231, Methods for using (-)-perhexiline, University of Adelaide, Heart Metabolics Ltd (Ireland) and Central Adelaide Local Health Network, 11 September 2015
WO/2015/131220, Composition and method for enhancing wound healing, Mark Tuffley, 11 September 2015
WO/2015/127512, Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders, Deakin University, 3 September 2015
WO/2015/127501, Combination method for treatment of cancer, Viralytics Ltd, 3 September 2015
WO/2015/123734, Liquid carrier materials, University of Sydney and Sydney Children's Hospital Network, 27 August 2015
WO/2015/123728, Mycoplasma surface proteins and uses thereof, University of Technology Sydney, 27 August 2015
WO/2015/123722, Inhibitors, Bionomics Ltd, 27 August 2015
WO/2015/123715, Ligand binding molecules and uses thereof, Opthea Ltd, 27 August 2015
WO/2015/117206, Improved aptamers, Deakin University and University of Southern Denmark (Denmark), 13 August 2015
WO/2015/117202, Functionalised benzopyran compounds and use thereof, Novogen Ltd, 13 August 2015
WO/2015/117201, Aptamer construct, Deakin University, 13 August 2015
WO/2015/117196, Antibacterial agents, University of Queensland, 13 August 2015
WO/2015/114062, New target for diabetes treatment and prevention, Universite De Strasbourg (France), INSERM (France) and Vaxine Pty Ltd, 6 August 2015
WO/2015/109367, Treatment of neoplasia, Sirtex Medical Ltd, 30 July 2015
WO/2015/109362, Method for reducing total gas production and/or methane production in a ruminant animal, Commonwealth Scientific and Industrial Research Organisation, Meat and Livestock Australia Ltd and James Cook University, 30 July 2015
WO/2015/107384, Pediculicidal composition, Hatchtech Pty Ltd, 23 July 2015
WO/2015/106311, Cell surface prostate cancer antigen for diagnosis, Minomic International Ltd, 23 July 2015
WO/2015/095932, Stabilized stannous compositions, University of Melbourne, 2 July 2015
WO/2015/095925, Fusion proteins comprising Factor IX for prophylactic treatment of hemophilia and methods thereof, CSL Ltd, 2 July 2015
WO/2015/095918, Treatment of pain, Innovative Herbal Products (Aust) Pty Ltd, 2 July 2015
WO/2015/089590, Method of synthesis of silica vesicles and use thereof, University of Queensland, 25 June 2015
WO/2015/089585, Method of treating wounds, CSL Ltd and B-Creative Sweden AB, 25 June 2015
WO/2015/089575, Method of diagnosis and treatment, Paranta Biosciences Ltd, 25 June 2015
WO/2015/089559, Optimising bioavailability of intra vitreally injectable steroids, Eye Co. Pty Ltd, 25 June 2015
WO/2015/085373, Method of treatment of alopecia with monoterpenoids, Cellmid Ltd, 18 June 2015
WO/2015/085351, Pharmaconutrient composition, University of New South Wales, 18 June 2015
WO/2015/085348, Apparatus for producing therapeutically active proteins in blood and uses thereof, Cytokine Medical Australia Pty Ltd, 18 June 2015
WO/2015/077845, Method of treating nephropathy, CSL Ltd and B-Creative Sweden AB, 4 June 2015
WO/2015/077844, Method of treating cancer, CSL Ltd and Ludwig Institute for Cancer Research (US), 4 June 2015
WO/2015/077831, Mikto-arm branched polymers, Commonwealth Scientific and Industrial Research Organisation, 4 June 2015
WO/2015/074124, Functionalised and substituted indoles as anti-cancer agents, Novogen Ltd, 28 May 2015
WO/2015/074123, Functionalised and substituted indoles as anti-cancer agents, Novogen Ltd, 28 May 2015
WO/2015/074115, Prevention and treatment of toxicosis, Meat and Livestock Australia Ltd and Charles Sturt University, 28 May 2015
WO/2015/074114, Stress management in livestock, Charles Sturt University, 28 May 2015
WO/2015/074103, Regimen and method for treatment of Type 2 Diabetes, Omniblend Innovation Pty Ltd, 28 May 2015
WO/2015/074102, Composition and method for control of post-prandial glucose, Omniblend Innovation Pty Ltd, 28 May 2015
WO/2015/071811, Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (gord/gerd), KFSU Ltd, 21 May 2015
WO/2015/070280, Senescence and senescence associated secretory phenotype, University of New South Wales, 21 May 2015
WO/2015/066767, Therapeutic compositions, Yale University (US) and Flinders University, 14 May 2015
WO/2015/061860, Vasodilator formulation and method of use, ATP Institute Pty Ltd, 7 May 2015
WO/2015/061856, Neuroprotective peptides, University of Western Australia, 7 May 2015
WO/2015/061847, Pain relief formulation and method of treatment, ATP Institute Pty Ltd, 7 May 2015
WO/2015/061832, Pharmaceutical combinations for the treatment of cancer, PharmAust Ltd and University of New South Wales, 7 May 2015
WO/2015/061829, Cooling solution and methods of use, Magna Carta Pty Ltd, 7 May 2015
WO/2015/061826, Novel scorpion toxin analogue and method for treating autoimmune diseases, Monash University, Peptides International (US) and Baylor College of Medicine (US), 7 May 2015
WO/2015/058258, Aβ modulating peptides, Alzhyme Pty Ltd, 30 April 2015
WO/2015/054730, Compositions and methods of administering same, Palmaya Pty Ltd, 23 April 2015
WO/2015/054718, Bone formation, University of Sydney, 23 April 2015
WO/2015/049589, Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma, EnGeneIC Ltd, 9 April 2015
WO/2015/048844, A method of producing exosomes, Xosoma Pty Ltd, 9 April 2015
WO/2015/048842, Biomarkers for cell therapy, Cell Ideas Pty Ltd, 9 April 2015
WO/2015/044395, Organometallic N-2-Cyano-1-Hydroxypropan-2-yl for use as anthelmintics, Universität Zürich (Switzerland) and University of Melbourne, 2 April 2015
WO/2015/042664, Novel immunotherapeutic composition and uses thereof, Monash University and Alfred Health, 2 April 2015
WO/2015/042639, Method of extracting protein, Hospira, 2 April 2015
WO/2015/039189, Modified anti-inflammatory proteins and method of use, James Cook University, 26 March 2015
WO/2015/039188, Anti-inflammatory proteins and methods of use, James Cook University, 26 March 2015
WO/2015/039187, Stem cell modulation II, University of Canberra, 26 March 2015
WO/2015/039173, Compositions for the treatment of hypertension and/or fibrosis, Vectus Biosystems, 26 March 2015
WO/2015/039172, Compositions for the treatment of hypertension and/or fibrosis, Vectus Biosystems, 26 March 2015
WO/2015/037747, Anticancer agent comprising aminoacetonitrile compound as active ingredient, Nihon Nohyaku Co. (Japan) and PharmAust Ltd, 19 March 2015
WO/2015/036986, Wound fluid elevated protease enzyme inhibition through camelid blood products, Patrick Prendergast, 19 March 2015
WO/2015/035475, Silica micro- and nano-capsules and methods for making them, University of Queensland, 19 March 2015
WO/2015/035474, Serological test, University of Melbourne, 19 March 2015
WO/2015/035460, Antisense oligomers and methods for treating SMN-related pathologies, University of Western Australia, 19 March 2015
WO/2015/035446, Macromolecules of dendrimer-platinum conjugates, Starpharma Ltd, 19 March 2015
WO/2015/035231, Antisense-induced exon2 inclusion in acid alpha-glucosidase, Sarepta Therapeutics (US) and Murdoch University, 12 March 2015
WO/2015/031958, Regulatory molecules, Garvan Institute of Medical Research, 12 March 2015
WO/2015/031950, Modified bacterial collagen-like proteins, Commonwealth Scientific and Industrial Research Organisation, 12 March 2015
WO/2015/027296, A method of treatment, University of Melbourne, 5 March 2015
WO/2015/024063, Formation of sub-nano metal particles, University of South Australia, 26 February 2015
WO/2015/024060, Immunoreceptor modulation for treating cancer and viral infections, QIMR Berghofer Medical Research Institute, 26 February 2015
WO/2015/024055, Separation of omega-3 fatty acids, Deakin University, 26 February 2015
WO/2015/024042, Immunoreceptor modulation for treating cancer and viral infections, QIMR Berghofer Medical Research Institute, 26 February 2015
WO/2015/021512, Sugar cane derived extracts and methods of treatment, Horizon Science Pty Ltd, 19 February 2015
WO/2015/021508, Regeneration of damaged tissue, University of Sydney, 19 February 2015
WO/2015/017901, Wheat having high levels of beta-glucan, Commonwealth Scientific and Industrial Research Organisation, 12 February 2015
WO/2015/017900, An antibody therapy for amyloid beta disease, St. Vincent's Institute of Medical Research, 12 February 2015
WO/2015/017888, Contaminant removal method, CSL Ltd, 12 February 2015
WO/2015/013739, Attenuated babesia vaccine, Griffith University, 5 February 2015
WO/2015/010166, Compositions and methods for dental mineralization, University of Melbourne, 29 January 2015
WO/2015/006833, A method for treating Type 1 Diabetes, St. Vincent's Institute of Medical Research, 22 January 2015
WO/2015/006803, UV absorbing compounds, compositions comprising same and uses thereof, Coral Sunscreen Pty Ltd, 22 January 2015
WO/2015/000929, N-(1-Cyano-2-Hydroxy-1-Methyl-Ethyl)-4-(Trifluoromethylsulfanyl)Benzamide derivatives for use as nematocidal drugs, Universität Zürich (Switzerland) and University of Melbourne, 8 January 2015
WO/2015/000035, Method for preventing and/or treating chronic traumatic encephalopathy-IV, Pressura Neuro, 8 January 2015
WO/2015/000034, Method for preventing and/or treating chronic traumatic encephalopathy-III, Pressura Neuro, 8 January 2015
WO/2015/000033, Method for preventing and/or treating chronic traumatic encephalopathy-II, Pressura Neuro, 8 January 2015
WO/2015/000032, Method for preventing and/or treating chronic traumatic encephalopathy-I, Pressura Neuro, 8 January 2015
WO/2015/000022, Treatment and prevention of mastitis, University of Adelaide, 8 January 2015
WO/2015/000014, Diagnosis and treatment of autoimmune diseases, University of New South Wales, 8 January 2015
WO/2015/000012, Radiolabelled material, Australian National University, 8 January 2015

New Zealand applications

Here are the 24 PCT patent applications relevant to New Zealand's Life Sciences sector that published in 2015, for a publication rate of 0.5 applications per week:

WO/2015/199555, Polymers for coating nanoparticles, Victoria Link, 30 December 2015
WO/2015/194970, Method of treating or preventing Multiple Sclerosis using one or more neural regeneration peptides, CuroNZ, 23 December 2015
WO/2015/187040, Amino sphingoglycolipid analogues, Regan Anderson et. al., 10 December 2015
WO/2015/183106, Use of allene oxide synthase for semen preservation and assisted reproduction, Pacific Brands, 3 December 2015
WO/2015/170993, A Matrix-Metalloproteinase (MMP) inhibitory extract and methods of use thereof, Comvita, 12 November 2015
WO/2015/147655, Stable veterinary anthelmintic formulations, Donaghys, 1 October 2015
WO/2015/145269, Method for the treatment of damaged tissue, Patrick Casey, 1 October 2015
WO/2015/119512, Polymer particles and uses thereof, Bernd Rehm, 13 August 2015
WO/2015/118468, Ectoparasite formulation, Argenta, 13 August 2015
WO/2015/095227, Peptidomimetic compounds and antibody-drug conjugates thereof, Genentech (US) with University of Auckland, 25 June 2015
WO/2015/084188, Method of treating or preventing epilepsy or seizures using one or more neural regeneration peptides, CuroNZ, 11 June 2015
WO/2015/084187, Functionalizing nanofibres, Kode Biotech, 11 June 2015
WO/2015/084181, Furo[3,4-B]pyran compounds and pharmaceutical uses, Victoria Link, 11 June 2015
WO/2015/080603, Glycoproteins, Antony Fairbanks, 4 June 2015
WO/2015/053636, Veterinary formulations and methods, Gary Harrison, 16 April 2015
WO/2015/041544, Bee venom compositions and uses, Honeylab, 26 March 2015
WO/2015/033211, High osteocalcin microcrystalline hydroxyapatite for calcium supplement, Waitaki Biosciences, 12 March 2015
WO/2015/030609, Anti-inflammatory compositions, methods and uses thereof, Apimed Medical Honey, 5 March 2015
WO/2015/030605, Honey compositions, Honeylab, 5 March 2015
WO/2015/028892, Reaction platform and method for making pollen based materials in combination with beeswax and uses thereof, Decima Health, 5 March 2015
WO/2015/026245, Beta-casein A2 and blood glucose levels, The A2 Milk Company, 26 February 2015
WO/2015/013397, Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders, Neuren Pharmaceuticals, 29 January 2015
WO/2015/008166, Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment, Patrick Casey and Murray Hoare, 22 January 2015
WO/2015/005804, Beta-casein A2 and reducing or preventing symptoms of lactose intolerance, The A2 Milk Company, 15 January 2015